nodes	percent_of_prediction	percent_of_DWPC	metapath
Glycine—GLRA2—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.053	0.0781	CbGpPWpGaD
Glycine—GLRA3—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.053	0.0781	CbGpPWpGaD
Glycine—GLRB—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0432	0.0637	CbGpPWpGaD
Glycine—GLRA1—Ligand-gated ion channel transport—GABRA2—conduct disorder	0.0341	0.0503	CbGpPWpGaD
Glycine—SLC6A5—brain—conduct disorder	0.0309	0.096	CbGeAlD
Glycine—GLYATL2—brain—conduct disorder	0.0263	0.0816	CbGeAlD
Glycine—SLC32A1—brain—conduct disorder	0.0242	0.0753	CbGeAlD
Glycine—GLRA3—brain—conduct disorder	0.0234	0.0727	CbGeAlD
Glycine—SLC6A9—brain—conduct disorder	0.0234	0.0727	CbGeAlD
Glycine—GCSH—brain—conduct disorder	0.0191	0.0593	CbGeAlD
Glycine—SLC32A1—Synaptic Vesicle Pathway—SLC6A4—conduct disorder	0.0184	0.0271	CbGpPWpGaD
Glycine—GNMT—brain—conduct disorder	0.0167	0.0518	CbGeAlD
Glycine—GLRA2—brain—conduct disorder	0.0162	0.0504	CbGeAlD
Glycine—SLC32A1—Neurotransmitter Release Cycle—MAOA—conduct disorder	0.0162	0.0239	CbGpPWpGaD
Glycine—GLDC—brain—conduct disorder	0.0158	0.0491	CbGeAlD
Glycine—PIPOX—brain—conduct disorder	0.0148	0.0459	CbGeAlD
Glycine—GCAT—brain—conduct disorder	0.0143	0.0445	CbGeAlD
Glycine—ALAS1—brain—conduct disorder	0.0125	0.039	CbGeAlD
Glycine—GRIN2C—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0122	0.018	CbGpPWpGaD
Glycine—GLRA2—Ion channel transport—GABRA2—conduct disorder	0.0115	0.0169	CbGpPWpGaD
Glycine—GLRA3—Ion channel transport—GABRA2—conduct disorder	0.0115	0.0169	CbGpPWpGaD
Glycine—GARS—brain—conduct disorder	0.0114	0.0355	CbGeAlD
Glycine—GPR18—GPCRs, Other—DRD4—conduct disorder	0.0114	0.0168	CbGpPWpGaD
Glycine—GATM—Amino acid and derivative metabolism—CGA—conduct disorder	0.0114	0.0168	CbGpPWpGaD
Glycine—GRIN2C—brain—conduct disorder	0.0112	0.035	CbGeAlD
Glycine—GATM—brain—conduct disorder	0.0109	0.0337	CbGeAlD
Glycine—SHMT2—brain—conduct disorder	0.00994	0.0309	CbGeAlD
Glycine—SLC32A1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00971	0.0143	CbGpPWpGaD
Glycine—AGXT—Amino acid and derivative metabolism—CGA—conduct disorder	0.0097	0.0143	CbGpPWpGaD
Glycine—GLYATL2—Phase II conjugation—COMT—conduct disorder	0.00945	0.0139	CbGpPWpGaD
Glycine—GLYAT—Phase II conjugation—COMT—conduct disorder	0.00945	0.0139	CbGpPWpGaD
Glycine—GLYATL1—Phase II conjugation—COMT—conduct disorder	0.00945	0.0139	CbGpPWpGaD
Glycine—GLRB—Ion channel transport—GABRA2—conduct disorder	0.00937	0.0138	CbGpPWpGaD
Glycine—SLC6A9—NRF2 pathway—SLC6A4—conduct disorder	0.00933	0.0138	CbGpPWpGaD
Glycine—SLC6A5—NRF2 pathway—SLC6A4—conduct disorder	0.00933	0.0138	CbGpPWpGaD
Glycine—GLRB—brain—conduct disorder	0.00932	0.029	CbGeAlD
Glycine—GRIN2A—Hypothetical Network for Drug Addiction—DRD4—conduct disorder	0.0093	0.0137	CbGpPWpGaD
Glycine—SHMT1—brain—conduct disorder	0.00905	0.0281	CbGeAlD
Glycine—AGXT2—Amino acid and derivative metabolism—CGA—conduct disorder	0.00825	0.0122	CbGpPWpGaD
Glycine—GRIN2A—brain—conduct disorder	0.00777	0.0241	CbGeAlD
Glycine—SLC36A1—brain—conduct disorder	0.00772	0.024	CbGeAlD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00759	0.0112	CbGpPWpGaD
Glycine—GPR18—GPCRs, Other—HTR2A—conduct disorder	0.00745	0.011	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—GABRA2—conduct disorder	0.00744	0.011	CbGpPWpGaD
Glycine—GLRA1—Ion channel transport—GABRA2—conduct disorder	0.00741	0.0109	CbGpPWpGaD
Glycine—GSS—brain—conduct disorder	0.0068	0.0211	CbGeAlD
Glycine—SHMT1—Amino acid and derivative metabolism—CGA—conduct disorder	0.00672	0.00991	CbGpPWpGaD
Glycine—GRIN2C—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00626	0.00923	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—CGA—conduct disorder	0.00578	0.00852	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—COMT—conduct disorder	0.00553	0.00815	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—COMT—conduct disorder	0.00553	0.00815	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—COMT—conduct disorder	0.00553	0.00815	CbGpPWpGaD
Glycine—GLYATL1—Biological oxidations—MAOA—conduct disorder	0.00549	0.00809	CbGpPWpGaD
Glycine—GLYAT—Biological oxidations—MAOA—conduct disorder	0.00549	0.00809	CbGpPWpGaD
Glycine—GLYATL2—Biological oxidations—MAOA—conduct disorder	0.00549	0.00809	CbGpPWpGaD
Glycine—GLYATL1—Metapathway biotransformation—COMT—conduct disorder	0.00545	0.00804	CbGpPWpGaD
Glycine—GLYAT—Metapathway biotransformation—COMT—conduct disorder	0.00545	0.00804	CbGpPWpGaD
Glycine—GLYATL2—Metapathway biotransformation—COMT—conduct disorder	0.00545	0.00804	CbGpPWpGaD
Glycine—GSS—Phase II conjugation—COMT—conduct disorder	0.00543	0.008	CbGpPWpGaD
Glycine—GPR18—G alpha (i) signalling events—DRD4—conduct disorder	0.00534	0.00788	CbGpPWpGaD
Glycine—BAAT—Metapathway biotransformation—COMT—conduct disorder	0.0052	0.00767	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00496	0.00731	CbGpPWpGaD
Glycine—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00478	0.00705	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00471	0.00694	CbGpPWpGaD
Glycine—SLC6A5—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00471	0.00694	CbGpPWpGaD
Glycine—SLC6A9—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00471	0.00694	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00467	0.00689	CbGpPWpGaD
Glycine—SLC32A1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00464	0.00684	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00449	0.00661	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00425	0.00626	CbGpPWpGaD
Glycine—GLRA2—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.004	0.0059	CbGpPWpGaD
Glycine—GLRA3—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.004	0.0059	CbGpPWpGaD
Glycine—SLC32A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.004	0.0059	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00387	0.00571	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—GABRA2—conduct disorder	0.00361	0.00532	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00359	0.0053	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—COMT—conduct disorder	0.00358	0.00528	CbGpPWpGaD
Glycine—SLC32A1—Neuronal System—MAOA—conduct disorder	0.00356	0.00524	CbGpPWpGaD
Glycine—GARS—Gene Expression—POLR3A—conduct disorder	0.00338	0.00499	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—CGA—conduct disorder	0.00326	0.00481	CbGpPWpGaD
Glycine—GLRB—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00326	0.00481	CbGpPWpGaD
Glycine—GPR18—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00324	0.00477	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—DRD4—conduct disorder	0.00324	0.00477	CbGpPWpGaD
Glycine—GSS—Biological oxidations—COMT—conduct disorder	0.00318	0.00468	CbGpPWpGaD
Glycine—GSS—Biological oxidations—MAOA—conduct disorder	0.00315	0.00465	CbGpPWpGaD
Glycine—GSS—Metapathway biotransformation—COMT—conduct disorder	0.00313	0.00462	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—CGA—conduct disorder	0.00296	0.00437	CbGpPWpGaD
Glycine—ALAS1—PPARA activates gene expression—EP300—conduct disorder	0.00279	0.00412	CbGpPWpGaD
Glycine—GPR18—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00277	0.00409	CbGpPWpGaD
Glycine—ALAS2—Metabolism—CGA—conduct disorder	0.00276	0.00407	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—GABRA2—conduct disorder	0.00275	0.00406	CbGpPWpGaD
Glycine—ALAS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00273	0.00403	CbGpPWpGaD
Glycine—SHMT1—Validated targets of C-MYC transcriptional activation—EP300—conduct disorder	0.0026	0.00384	CbGpPWpGaD
Glycine—GLRA1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.00258	0.0038	CbGpPWpGaD
Glycine—SLC36A1—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0023	0.00339	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—COMT—conduct disorder	0.00227	0.00334	CbGpPWpGaD
Glycine—GRIN2C—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00225	0.00332	CbGpPWpGaD
Glycine—GPR18—GPCR ligand binding—HTR2A—conduct disorder	0.00211	0.00311	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—CGA—conduct disorder	0.00209	0.00309	CbGpPWpGaD
Glycine—GATM—Metabolism—CGA—conduct disorder	0.00209	0.00309	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—CGA—conduct disorder	0.00209	0.00309	CbGpPWpGaD
Glycine—GLYAT—Metabolism—CGA—conduct disorder	0.00209	0.00309	CbGpPWpGaD
Glycine—BAAT—Metabolism—CGA—conduct disorder	0.002	0.00295	CbGpPWpGaD
Glycine—ALAS1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.00188	0.00278	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—DRD4—conduct disorder	0.00183	0.0027	CbGpPWpGaD
Glycine—AGXT—Metabolism—CGA—conduct disorder	0.00178	0.00263	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—CGA—conduct disorder	0.00175	0.00258	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—COMT—conduct disorder	0.00174	0.00256	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—COMT—conduct disorder	0.00173	0.00255	CbGpPWpGaD
Glycine—ALAS1—Metabolism—CGA—conduct disorder	0.00172	0.00254	CbGpPWpGaD
Glycine—GRIN2C—Neuronal System—MAOA—conduct disorder	0.00172	0.00254	CbGpPWpGaD
Glycine—GRIN2A—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00172	0.00253	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—DRD4—conduct disorder	0.00166	0.00245	CbGpPWpGaD
Glycine—AGXT2—Metabolism—CGA—conduct disorder	0.00151	0.00223	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—WASF1—conduct disorder	0.0014	0.00207	CbGpPWpGaD
Glycine—SLC16A10—Transmembrane transport of small molecules—GABRA2—conduct disorder	0.0014	0.00206	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—COMT—conduct disorder	0.00133	0.00195	CbGpPWpGaD
Glycine—GRIN2A—Neuronal System—MAOA—conduct disorder	0.00132	0.00194	CbGpPWpGaD
Glycine—ALAS2—Metabolism—COMT—conduct disorder	0.00125	0.00184	CbGpPWpGaD
Glycine—ALAS2—Metabolism—MAOA—conduct disorder	0.00124	0.00183	CbGpPWpGaD
Glycine—SHMT1—Metabolism—CGA—conduct disorder	0.00123	0.00182	CbGpPWpGaD
Glycine—GSS—Metabolism—CGA—conduct disorder	0.0012	0.00177	CbGpPWpGaD
Glycine—GPR18—GPCR downstream signaling—HTR2A—conduct disorder	0.00119	0.00176	CbGpPWpGaD
Glycine—GPR18—Signaling by GPCR—HTR2A—conduct disorder	0.00108	0.0016	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—DRD4—conduct disorder	0.000981	0.00145	CbGpPWpGaD
Glycine—GATM—Metabolism—COMT—conduct disorder	0.000946	0.00139	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—COMT—conduct disorder	0.000946	0.00139	CbGpPWpGaD
Glycine—GLYAT—Metabolism—COMT—conduct disorder	0.000946	0.00139	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—COMT—conduct disorder	0.000946	0.00139	CbGpPWpGaD
Glycine—GATM—Metabolism—MAOA—conduct disorder	0.000939	0.00138	CbGpPWpGaD
Glycine—GLYAT—Metabolism—MAOA—conduct disorder	0.000939	0.00138	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—MAOA—conduct disorder	0.000939	0.00138	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—MAOA—conduct disorder	0.000939	0.00138	CbGpPWpGaD
Glycine—BAAT—Metabolism—COMT—conduct disorder	0.000902	0.00133	CbGpPWpGaD
Glycine—BAAT—Metabolism—MAOA—conduct disorder	0.000896	0.00132	CbGpPWpGaD
Glycine—BAAT—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000869	0.00128	CbGpPWpGaD
Glycine—AGXT—Metabolism—COMT—conduct disorder	0.000804	0.00119	CbGpPWpGaD
Glycine—AGXT—Metabolism—MAOA—conduct disorder	0.000798	0.00118	CbGpPWpGaD
Glycine—ALAS1—Metabolism—COMT—conduct disorder	0.000779	0.00115	CbGpPWpGaD
Glycine—ALAS1—Metabolism—MAOA—conduct disorder	0.000773	0.00114	CbGpPWpGaD
Glycine—ALAS1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00075	0.00111	CbGpPWpGaD
Glycine—AGXT2—Metabolism—COMT—conduct disorder	0.000684	0.00101	CbGpPWpGaD
Glycine—AGXT2—Metabolism—MAOA—conduct disorder	0.000679	0.001	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—HTR2A—conduct disorder	0.00064	0.000943	CbGpPWpGaD
Glycine—SHMT1—Metabolism—COMT—conduct disorder	0.000557	0.000822	CbGpPWpGaD
Glycine—SHMT1—Metabolism—MAOA—conduct disorder	0.000553	0.000816	CbGpPWpGaD
Glycine—GSS—Metabolism—COMT—conduct disorder	0.000543	0.000801	CbGpPWpGaD
Glycine—GSS—Metabolism—MAOA—conduct disorder	0.000539	0.000795	CbGpPWpGaD
Glycine—ALAS2—Metabolism—EP300—conduct disorder	0.000535	0.000789	CbGpPWpGaD
Glycine—GLYAT—Metabolism—EP300—conduct disorder	0.000405	0.000598	CbGpPWpGaD
Glycine—GLYATL2—Metabolism—EP300—conduct disorder	0.000405	0.000598	CbGpPWpGaD
Glycine—GLYATL1—Metabolism—EP300—conduct disorder	0.000405	0.000598	CbGpPWpGaD
Glycine—GATM—Metabolism—EP300—conduct disorder	0.000405	0.000598	CbGpPWpGaD
Glycine—BAAT—Metabolism—EP300—conduct disorder	0.000387	0.00057	CbGpPWpGaD
Glycine—AGXT—Metabolism—EP300—conduct disorder	0.000345	0.000508	CbGpPWpGaD
Glycine—GPR18—Signaling Pathways—EP300—conduct disorder	0.000339	0.0005	CbGpPWpGaD
Glycine—ALAS1—Metabolism—EP300—conduct disorder	0.000334	0.000492	CbGpPWpGaD
Glycine—AGXT2—Metabolism—EP300—conduct disorder	0.000293	0.000432	CbGpPWpGaD
Glycine—SHMT1—Disease—EP300—conduct disorder	0.000285	0.000421	CbGpPWpGaD
Glycine—SHMT1—Metabolism—EP300—conduct disorder	0.000239	0.000352	CbGpPWpGaD
Glycine—GSS—Metabolism—EP300—conduct disorder	0.000233	0.000343	CbGpPWpGaD
